An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states
Nippon Express has provided a pharmaceutical distribution platform with strict temperature control in two ranges -- 2 C to 8 C
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
Subscribe To Our Newsletter & Stay Updated
